Real-World Effectiveness of Gliclazide MR vs. Sitagliptin as Second-Line Therapy in People with Type 2 Diabetes Uncontrolled on Metformin

被引：0
|
作者：
Zaccardi, Francesco
Cortese, Viviana
Jacquot, Emmanuelle
Tyrer, Freya
Seidu, Samuel
Davies, Melanie J.
Khunti, Kamlesh
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1062-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1062-P
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Comparative effectiveness of gliclazide modified release versus sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes
    Zaccardi, Francesco
    Jacquot, Emmanuelle
    Cortese, Viviana
    Tyrer, Freya
    Seidu, Samuel
    Davies, Melanie J.
    Khunti, Kamlesh
    DIABETES OBESITY & METABOLISM, 2020, 22 (12): : 2417 - 2426
  • [2] Efficacy and safety of replacing sitagliptin with canagliflozin in real-world patients with type 2 diabetes uncontrolled with sitagliptin combined with metformin and/or gliclazide: The SITA-CANA Switch Study
    Garcia de Lucas, M. D.
    Perez Belmonte, L. M.
    Suarez Tembra, M.
    Olalla Sierra, J.
    Gomez Huelgas, R.
    DIABETES & METABOLISM, 2018, 44 (04) : 373 - 375
  • [3] REAL-WORLD EFFECTIVENESS OF SGLT2 INHIBITORS VS METFORMIN AS FIRST-LINE THERAPY IN TYPE 2 DIABETES
    Rodriguez, P.
    Gratzl, S.
    Lee, R.
    Gilson, S.
    Smits, P.
    Stucky, N.
    Gluckman, T. J.
    VALUE IN HEALTH, 2023, 26 (06) : S32 - S33
  • [4] Relationship between Diabetes Duration and Real-World Effectiveness of Second-Line Dual OAD Therapy
    Brath, Helmut
    Paldanius, Paeivi M.
    Bader, Giovanni
    Mathieu, Chantal
    DIABETES, 2015, 64 : A315 - A316
  • [5] Cost-effectiveness of saxagliptin vs glimepiride as a second-line therapy added to metformin in Type 2 diabetes in China
    Gu, Shuyan
    Deng, Jing
    Shi, Lizheng
    Mu, Yiming
    Dong, Hengjin
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (10) : 808 - 820
  • [6] Triple vs. Dual Therapy with Saxagliptin plus Dapagliflozin vs. Sitagliptin Added to Metformin-Failure Uncontrolled Type 2 Diabetes
    Handelsman, Yehuda
    Mathieu, Chantal
    Del Prato, Stefano
    Johnsson, Eva
    Kurlyandskaya, Raisa
    Iqbal, Nayyar
    Rosenstock, Julio
    DIABETES, 2017, 66 : A35 - A36
  • [7] Real-World Effectiveness of Sitagliptin as Add-On Therapy in Patients With Type 2 Diabetes Mellitus
    Chen, Tse-Ying
    Hsieh, Ching-Jung
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 205 - 215
  • [8] Cost-Effectiveness of Empagliflozin vs. Liraglutide as Second-Line Therapy for Type 2 Diabetes in the United States
    Reifsnider, Odette
    Pimple, Pratik
    Stargardter, Matthew J. D.
    Brand, Sarah
    Desai, Nihar
    Shetty, Sharash
    DIABETES, 2020, 69
  • [9] Choosing a second-line therapy after metformin in type 2 diabetes mellitus
    Carol Wilson
    Nature Reviews Endocrinology, 2012, 8 (8) : 441 - 441
  • [10] Comparative Effectiveness of Second-Line Initiation of Basal Insulin Therapy vs. Oral Antidiabetic Drugs Added to Metformin among Patients with Type 2 Diabetes in Taiwan
    Chen, Pin-Hao
    Kuo, Shihchen
    Ou, Huang-Tz
    DIABETES, 2019, 68
12345